Charts
4575:キャンバス
Remove from History
Add to History
諸事情によりHistoryの登録はログインユーザーに限定。
Current:
720.0
PreviousClose:
738.0
Open:
738.0
High:
746.0
Low:
719.0
Dividend History None
EPS:
-64.21
BPS:
105.212
ROA:
-30.5%
ROE:
-50.6%
CanBas Co., Ltd., a clinical stage biopharmaceutical company, engages in the basic research and clinical development of anti-cancer drugs. It develops CBP501, a compound which regulates the regulatory function of the protein calmodulin in Phase 2 clinical trials targeting non-small cell lung cancer; and CBS9106 for patients with advanced solid tumors. CanBas Co., Ltd. was incorporated in 2000 and is based in Numazu, Japan.